Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacques P Tremblay

Showing results (71-80 of 139) with videos related to

Pageof 14
Sort By:
International Journal of Molecular Sciences|June 10, 2022
Prime Editing Permits the Introduction of Specific Mutations in the Gene Responsible for Duchenne Muscular DystrophyCédric Happi Mbakam, Joël Rousseau, Guillaume Tremblay, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 6, 2016
Gene Editing for Duchenne Muscular Dystrophy Using the CRISPR/Cas9 Technology: The Importance of Fine-tuning the ApproachJacques P Tremblay, Jean-Paul Iyombe-Engembe, Benjamin Duchêne, et al.
Cell Transplantation|May 4, 2011
Fibrin gel improves the survival of transplanted myoblastsCatherine Gerard, Marie Anne Forest, Genevieve Beauregard, et al.
Frontiers in Genome Editing|August 12, 2022
Improvements of nuclease and nickase gene modification techniques for the treatment of genetic diseasesYaoyao Lu, Cedric Happi Mbakam, Bo Song, et al.
Cell Transplantation|July 31, 2007
1,25-dihydroxyvitamin D3 increases the transplantation success of human muscle precursor cells in SCID miceLionel Stephan, Manaf Bouchentouf, Philippe Mills, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 23, 2004
Novel Duchenne muscular dystrophy treatment through myoblast transplantation tolerance with anti-CD45RB, anti-CD154 and mixed chimerismGeoffrey Camirand, Joël Rousseau, Marie-Eve Ducharme, et al.
Mitochondrion|June 29, 2016
Characterization of frataxin gene network in Friedreich's ataxia fibroblasts using the RNA-Seq techniqueNoëlia Sanchez, Pierre Chapdelaine, Joël Rousseau, et al.
Molecular Human Reproduction|March 29, 2014
Generation of human endometrial knockout cell lines with the CRISPR/Cas9 system confirms the prostaglandin F2α synthase activity of aldo-ketoreductase 1B1Nicolas Lacroix Pépin, Pierre Chapdelaine, Yoima Rodriguez, et al.
Cells|May 27, 2026
Gene Editing Strategies for Duchenne Muscular Dystrophy: From Molecular Mechanisms to Clinical TranslationAyesha Siddika, Joël Rousseau, Félix Veillette, et al.
Cell Transplantation|January 10, 2003
Dynamics of the early immune cellular reactions after myogenic cell transplantationDaniel Skuk, Nicolas Caron, Marlyne Goulet, et al.
Pageof 14

Showing results (71-80 of 139) with videos related to

Sort By:
Pageof 14
International Journal of Molecular Sciences|June 10, 2022
Prime Editing Permits the Introduction of Specific Mutations in the Gene Responsible for Duchenne Muscular DystrophyCédric Happi Mbakam, Joël Rousseau, Guillaume Tremblay, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 6, 2016
Gene Editing for Duchenne Muscular Dystrophy Using the CRISPR/Cas9 Technology: The Importance of Fine-tuning the ApproachJacques P Tremblay, Jean-Paul Iyombe-Engembe, Benjamin Duchêne, et al.
Cell Transplantation|May 4, 2011
Fibrin gel improves the survival of transplanted myoblastsCatherine Gerard, Marie Anne Forest, Genevieve Beauregard, et al.
Frontiers in Genome Editing|August 12, 2022
Improvements of nuclease and nickase gene modification techniques for the treatment of genetic diseasesYaoyao Lu, Cedric Happi Mbakam, Bo Song, et al.
Cell Transplantation|July 31, 2007
1,25-dihydroxyvitamin D3 increases the transplantation success of human muscle precursor cells in SCID miceLionel Stephan, Manaf Bouchentouf, Philippe Mills, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|July 23, 2004
Novel Duchenne muscular dystrophy treatment through myoblast transplantation tolerance with anti-CD45RB, anti-CD154 and mixed chimerismGeoffrey Camirand, Joël Rousseau, Marie-Eve Ducharme, et al.
Mitochondrion|June 29, 2016
Characterization of frataxin gene network in Friedreich's ataxia fibroblasts using the RNA-Seq techniqueNoëlia Sanchez, Pierre Chapdelaine, Joël Rousseau, et al.
Molecular Human Reproduction|March 29, 2014
Generation of human endometrial knockout cell lines with the CRISPR/Cas9 system confirms the prostaglandin F2α synthase activity of aldo-ketoreductase 1B1Nicolas Lacroix Pépin, Pierre Chapdelaine, Yoima Rodriguez, et al.
Cells|May 27, 2026
Gene Editing Strategies for Duchenne Muscular Dystrophy: From Molecular Mechanisms to Clinical TranslationAyesha Siddika, Joël Rousseau, Félix Veillette, et al.
Cell Transplantation|January 10, 2003
Dynamics of the early immune cellular reactions after myogenic cell transplantationDaniel Skuk, Nicolas Caron, Marlyne Goulet, et al.
Pageof 14